Bolt Biotherapeutics, Inc. - BOLT

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$2.535M

QoQ value delta ($000)

-$752K (-22.88%)

Implied price effect (QoQ)

-25.46%

Total shares

623,431

QoQ shares delta

+20,893 (+3.47%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 24 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Sofinnova Investments, Inc.	556	137,721	0.02%
RENAISSANCE TECHNOLOGIES LLC	311	77,225	0.0%
Vivo Capital, LLC	292	72,414	0.02%
Pivotal bioVenture Partners Investment Advisor LLC	172	42,581	0.06%
T3 Companies, LLC	153	38,000	0.2%
Board of Trustees of The Leland Stanford Junior University	145	35,977	0.02%
PFIZER INC	137	31,305	0.06%
Lynx1 Capital Management LP	124	30,800	0.02%
Nan Fung Group Holdings Ltd	118	29,250	0.1%
GEODE CAPITAL MANAGEMENT, LLC	116	28,791	0.0%
NANO CAP NEW MILLENNIUM GROWTH FUND L P	111	27,500	0.1%
Shay Capital LLC	60	14,905	0.01%
VANGUARD GROUP INC	55	10,179	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	47	11,657	0.0%
CITADEL ADVISORS LLC	40	10,109	0.0%
BlackRock, Inc.	39	9,711	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	28	7,060	0.0%
MORGAN STANLEY	12	3,189	0.0%
VANGUARD FIDUCIARY TRUST CO	12	3,095	0.0%
Tower Research Capital LLC (TRC)	4	1,093	0.0%
UBS Group AG	3	787	0.0%
JPMORGAN CHASE & CO	0	42	0.0%
BARCLAYS PLC	0	6	0.0%
SBI Securities Co., Ltd.	0	10	0.0%
Vanguard Global Advisers, LLC	0	24	0.0%